×
0 0 0 0 0 0 0 0
Stockreport

Verastem Oncology prices registered direct offering of $150M convertible notes [Seeking Alpha]

Verastem, Inc (VSTM)  More Company Research Source: Seeking Alpha
Last verastem, inc earnings: 11/7 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Verastem (NASDAQ: VSTM ) prices its 5.00% Convertible Senior Notes due 2048 through a registered direct offering, for gross proceeds of $150M. The Convertible Notes will be paid semi-annually in arrears, and will mature on November 1, 204. Net proceeds of ~$145.4M will be used for the continued clinical development of COPIKTRA (duvelisib) and its other lead product candidates, and to fund working capital and other general corporate purposes. Closing date is October 17. Click to subscribe to real-time analytics on VSTM Now read: Long-Term Outlook For CRISPR Therapeutics: October 11, 2018 » Subscribe for full text news in your inbox [Read more]

IMPACT SNAPSHOT EVENT TIME: VSTM
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VSTM alerts
from News Quantified
Opt-in for
VSTM alerts

from News Quantified
Opt-in for
VSTM alerts

from News Quantified